GSK’s ViiV, Shionogi Settle Cipla Patent Suit on Dovato Drug (1)

GlaxoSmithKline PLC’s ViiV Healthcare and Shionogi & Co. settled a lawsuit alleging Cipla Ltd.’s proposed generic version of Dovato infringes a patent for the HIV treatment, according to a federal court filing in Delaware.

Judge Mitchell S. Goldberg on Monday approved the parties’ consent judgment filed in the U.S. District Court for the District of Delaware. No details of the settlement agreement were provided in the order, which blocks Cipla from making generic versions of Dovato until the patent has expired, “except as specifically authorized” in the agreement.

“Terms of the settlement are confidential,” a ViiV spokesperson said Wednesday. Cipla ...